Patents by Inventor Victor Söderberg

Victor Söderberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240024248
    Abstract: The present disclosure relates to the field of pharmaceutical compositions. Furthermore, the present invention relates to an immediate release pharmaceutical composition in the form of a non-effervescent tablet composition comprising dasatinib and a gas generating agent.
    Type: Application
    Filed: July 27, 2023
    Publication date: January 25, 2024
    Applicant: XSPRAY PHARMA AB
    Inventors: Magnus BRISANDER, Thomas MEIJER, Victor SÖDERBERG
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 11833249
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: December 5, 2023
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230121325
    Abstract: The present disclosure relates to the field of pharmaceutical compositions. Furthermore, the present invention relates to an immediate release pharmaceutical composition in the form of a non-effervescent tablet composition comprising dasatinib and a gas generating agent.
    Type: Application
    Filed: December 12, 2022
    Publication date: April 20, 2023
    Applicant: XSPRAY PHARMA AB
    Inventors: Magnus BRISANDER, Thomas MEIJER, Victor SÖDERBERG
  • Fast dissolving pharmaceutical compositions
    Patent number: 11529351
    Abstract: The present disclosure relates to the field of pharmaceutical compositions. Furthermore, the present invention relates to an immediate release pharmaceutical composition in the form of a non-effervescent tablet composition comprising dasatinib and a gas generating agent.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: December 20, 2022
    Assignee: XSPRAY PHARMA AB
    Inventors: Magnus Brisander, Thomas Meijer, Victor Söderberg
  • RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORMS CONTAINING DASATINIB
    Publication number: 20220257519
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Applicant: XSPRAY PHARMA AB
    Inventors: Per ANDERSSON, Thomas MEIJER, Victor SÖDERBERG
  • FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220233532
    Abstract: The present disclosure relates to the field of pharmaceutical compositions. Furthermore, the present invention relates to an immediate release pharmaceutical composition in the form of a non-effervescent tablet composition comprising dasatinib and a gas generating agent.
    Type: Application
    Filed: January 21, 2022
    Publication date: July 28, 2022
    Applicant: XSPRAY PHARMA AB
    Inventors: Magnus BRISANDER, Thomas MEIJER, Victor SÖDERBERG
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 11344500
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: May 31, 2022
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORMS CONTAINING DASATINIB
    Publication number: 20210085609
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Application
    Filed: December 2, 2020
    Publication date: March 25, 2021
    Applicant: XSPRAY PHARMA AB
    Inventors: Per ANDERSSON, Thomas MEIJER, Victor SÖDERBERG
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10894017
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: January 19, 2021
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10894018
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: January 19, 2021
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10874614
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 29, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10869836
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 22, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10869837
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 22, 2020
    Assignee: XSPRAY PHARMA AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg
  • Rapidly disintegrating solid oral dosage forms containing dasatinib
    Patent number: 10799459
    Abstract: The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: October 13, 2020
    Assignee: XSPRAY MICROPARTICLES AB
    Inventors: Per Andersson, Thomas Meijer, Victor Söderberg